Kanvas Biosciences develops microbiome mapping technology and live biotherapeutic products. Its HiPR-Map spatial imaging platform and Spectral Lightsheet microscope let researchers locate microbes inside the gut at high resolution, feeding a pipeline of immuno-oncology and gut-restoration drug candidates that include KAN-001 for solid-tumor patients who do not respond to immune checkpoint inhibitors.
1
Round
4
Tags
May 5, 2026
Latest raise
Funding activity · 1 round
May 5, 2026
$48M
Series A
Led by DCVC
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
